Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-22-012174
Filing Date
2022-11-08
Accepted
2022-11-08 16:30:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 28936
2 filename2.txt TEXT-EXTRACT 3500
  Complete submission text file 0000000000-22-012174.txt   44038
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filed for) CIK: 0001859007 (see all company filings)

EIN.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations